A cut in the official cash rate was not enough to boost the NZX today; rather Trump's tariffs ruled the day.

Very few stocks were spared as the New Zealand sharemarket had its biggest single-day fall since the start of the Covid pandemic following the global fall-out from the United States tariffs.

The New Zealand sharemarket fared better than most in a week that saw a rout on Wall Street following the introduction of sweeping United States tariffs.

The New Zealand sharemarket and Fisher and Paykel Healthcare had impressive turnarounds following the initial shock of President Donald Trump’s wide-ranging reciprocal tariffs on imported goods into United States.

Software firm Gentrack surged more than 10% on speculation it has won a major offshore contract, but the New Zealand sharemarket finished the week on a flat note.

The New Zealand sharemarket had a rocky session before finishing with a small loss, and leading retirement village operator Ryman Healthcare continued to move off a 13-year low.

A sharp gain by heavyweight Fisher and Paykel Healthcare pushed the New Zealand sharemarket to its biggest single-day rise in four months.

Telco Spark rose sharply on a broker’s upgrade as the improving New Zealand sharemarket, up nearly 0.5%, posted its fourth successive gain

The New Zealand sharemarket traded flat during a quieter day, but Fonterra Shareholders Fund broke through the $6 mark for the first time in seven years on the back of a buoyant dairy sector.

Blue-chip stocks were back in favour as the New Zealand sharemarket, looking a little undervalued, closed the week with a broad-based rally of nearly 0.5%.

The New Zealand sharemarket has now fallen in six of the last seven trading days but it may be heartened by upcoming news that the country has come out of a recession.

The New Zealand sharemarket reached its lowest level in nine months, with another 0.7% fall, following a month-long rout on Wall Street.

Leading telco Spark continued its slide, with a2 Milk hitting a four-year high, Smartpay having two takeover bids, and the New Zealand sharemarket starting the new week with a 0.8% fall.

Global marketer a2 Milk surged more than 7% on new China family policy, while the New Zealand sharemarket finished a volatile week with a strong bounce.

Retirement village operator Ryman Healthcare completed its $1 billion capital raise as the New Zealand sharemarket steadied the ship with a small loss.

Leading retailer Briscoe Group produced another solid annual result, but it couldn’t stop the New Zealand sharemarket falling more than 1% on the continued sell-down in the United States.